News from astute medical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 17, 2015, 07:00 ET
0by25 Logo

Astute Medical, Inc. Lauds Launch Of Global Initiative To End Acute Kidney Injury

 Astute Medical, Inc. today hailed the launch of a collaborative global initiative calling for the elimination of preventable deaths from acute...

Mar 16, 2015, 02:30 ET

Astute Medical, Inc. Previews International Intensive Care Meeting

 Astute Medical, Inc., developer of the NEPHROCHECK® Test, today previewed abstracts to be presented next week at the International...

Feb 12, 2015, 07:30 ET

Astute Medical, Inc. Previews AKI & CRRT 2015 Conference

 Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San...

Jan 22, 2015, 01:00 ET

bioMerieux and Astute Medical sign a global agreement to develop and market NEPHROCHECK® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury

bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to improving the diagnosis of...

Jan 13, 2015, 10:17 ET

New Study Shows Urinary Levels Of Novel Biomarkers Measured By Astute Medical's NephroCheck® Test Are Associated With Adverse Long-term Outcomes In Patients With Acute Kidney Injury

Citing a study recently published online in the Journal of the American Society of Nephrology (JASN), Astute Medical, Inc. Co-founder and Chief...

Oct 09, 2014, 07:30 ET

Astute Medical And CRG Announce FDA Milestone Under Term Loan Agreement

 Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement...

Sep 08, 2014, 09:00 ET
Astute Medical announced FDA clearance of its NeproCheck(R) Test System to aid in acute kidney injury risk assessment. The first-of-a-kind test in the United States checks for the presence of two biomarkers in a urine sample that indicate a patient is at-risk for developing moderate-to-severe kidney injury. (PRNewsFoto/Astute Medical, Inc.)

Astute Medical to Release First Test for Risk Assessment of Kidney Injury

A novel test used to assess risk for acute kidney injury (AKI) could help physicians significantly improve management of intensive care unit (ICU)...

Jul 28, 2014, 08:00 ET

Astute Medical And Ortho-Clinical Diagnostics Enter Strategic Collaboration To Advance Innovative Acute Kidney Injury Test

 Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new...

Apr 04, 2014, 02:00 ET

Astute Medical señala el éxito del análisis NephroCheck® Test

-- Astute Medical señala el éxito del análisis NephroCheck® Test en el estudio de la evaluación del riesgo de DRA en...

Apr 04, 2014, 02:00 ET

Astute Medical, Inc ottiene risultati positivi per il test NephroCheck® nello studio per la valutazione del rischio di IRA nei pazienti reduci da chirurgia cardiaca

Pubblicato questa settimana su PLOS ONE, uno studio osservazionale condotto dal Dott. Alexander Zarbock dell'Università di Münster. ...

Apr 04, 2014, 02:00 ET

Astute Medical, Inc. meldet Erfolg für den NephroCheck®-Test in einer AKI-Risikobewertungsstudie mit Patienten nach einer Herzoperation

In dieser Woche wird in PLOS ONE eine Beobachtungsstudie von Dr. Alexander Zarbock von der Universität Münster veröffentlicht. Mit...

Apr 04, 2014, 02:00 ET

Astute Medical annonce l'efficacité du test NephroCheck® dans une étude d'évaluation du risque d'IRA chez des patients ayant subi une chirurgie cardiaque

La revue scientifique PLOS ONE publie cette semaine une étude observationnelle du Dr Alexander Zarbock de l'université de Münster....

Mar 18, 2014, 17:19 ET

Astute Medical ospiterà il simposio sull'insufficienza renale acuta al 34o congresso annuale ISICEM

-- L'evento mette in evidenza l'utilizzo routinario del test NephroCheck® per la valutazione del rischio di IRA Su scala mondiale,...

Mar 18, 2014, 17:10 ET

Astute Medical va accueillir le Symposium portant sur l'insuffisance rénale aiguë du 34e ISICEM annuel

-- L'événement s'intéressera notamment à l'utilisation du test NephroCheck®  pour l'évaluation du risque...

Mar 18, 2014, 16:57 ET

Organizará el XXXIV simposio ISICEM anual sobre daño renal agudo

-- Un evento especialmente dedicado al uso habitual del análisis NephroCheck® Test para la evaluación del riesgo de DRA...

Mar 07, 2014, 01:00 ET

Un nuevo estudio valida el análisis NephroCheck® Test para el riesgo de daño renal agudo

 Un estudio multicéntrico publicado en el American Journal of Respiratory and Critical Care Medicine (AJRCCM) valida el rendimiento del...

Mar 06, 2014, 02:05 ET

Une nouvelle étude valide le test Nephrocheck® dans la détection du risque d'insuffisance rénale aiguë

 Une étude multicentrique publiée en ligne dans l'American Journal of Respiratory and Critical Care Medicine (AJRCCM) valide la...

Mar 06, 2014, 01:55 ET

Neue studie zur validierung des NephroCheck® Tests zur risikobewertung bei akutem nierenversagen

 Die American Journal of Respiratory and Critical Care Medicine (AJRCCM) online veröffentlichte multizentrische Studie validiert die...

Mar 06, 2014, 01:52 ET

Il nuovo studio valida il test Nephrocheck® per il rischio di danno renale acuto

 Uno studio multicentrico pubblicato online sull'American Journal of Respiratory and Critical Care Medicine (AJRCCM) convalida le prestazioni...

Mar 03, 2014, 07:00 ET

Astute Medical To Host Acute Kidney Injury Symposium At CRRT 2014

Leading critical care experts will discuss biomarkers for risk assessment of acute kidney injury (AKI) at an educational symposium to be held at...